Tag: biotech funding

BigHat’s robot lab reaches the clinic on a $75M round

BigHat's Milliner platform pairs frontier models with automated lab work, and its first antibody-drug conjugate is now in patients.

By

Basecamp Research targets DNA editing from inside the body

The London biotech's Series C values it at $800 million and funds EDEN models aimed at rewriting a patient's cells…

By

Enveda lands $311M to move three medicines into late-stage trials

Enveda closed a $311 million Series E led by Catalio to push three clinical-stage medicines deeper into development.

By

AbbVie signs a multi-year AI deal as Iambic files for Nasdaq

The San Diego drug designer lands a large pharma partner days before asking public investors to fund its pipeline.

By

Mithrl raises $20M for a biomedical world model aimed at R&D

The company says its platform can cut the time from a research idea to an investigational new drug filing by…

By

Aureka banks $100M Series B for biology foundation models

Aureka closes a $100M Series B to train biological foundation models for AI-driven drug discovery.

By

Chai Discovery raises $400M at $3.8B valuation for AI drug design

The AI biotech startup triples its valuation in eight months with backing from Lilly, Pfizer and Novartis partnerships.

By